Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial

被引:39
|
作者
Wanlapakorn, Nasamon [1 ,2 ]
Maertens, Kirsten [3 ]
Vongpunsawad, Sompong [1 ]
Puenpa, Jiratchaya [1 ]
Thao Mai Phuong Tran [4 ]
Hens, Niel [4 ,5 ]
Van Damme, Pierre [3 ]
Thiriard, Anais [6 ]
Raze, Dominique [6 ]
Locht, Camille [6 ]
Poovorawan, Yong [1 ]
Leuridan, Elke [3 ]
机构
[1] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand
[2] Chulalongkorn Univ, Div Acad Affairs, Fac Med, Bangkok, Thailand
[3] Univ Antwerp, Fac Med & Hlth Sci, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Univ Pl 1, B-2610 Antwerp, Belgium
[4] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium
[5] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, Antwerp, Belgium
[6] Univ Lille, Ctr Hosp Reg Univ Lille, CNRS,Inst Pasteur Lille, Ctr Infect & Immun Lille,U1019 UMR8204,INSERM, Lille, France
基金
欧洲研究理事会;
关键词
pertussis; pregnancy; maternal immunization; humoral immune response; functionality; PRIMARY IMMUNIZATION; IMMUNE-RESPONSES; IMMUNOGENICITY; TDAP; IMPACT; WOMEN;
D O I
10.1093/cid/ciz778
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The blunting effect of pertussis immunization during pregnancy on infant antibody responses induced by whole-cell pertussis (wP) vaccination is not well-defined. Methods. This randomized controlled trial (NCT02408926) followed term infants born to mothers vaccinated with tetanus, diphtheria, and acellular pertussis (Tdap) vaccine during pregnancy in Thailand. Infants received either acellular pertussis (aP)- or wP-containing vaccine at 2, 4, 6, and 18 months of age. A comparison group comprised wP-vaccinated children born to mothers not vaccinated during pregnancy. Antibodies against pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (PRN) were evaluated using commercial enzyme-linked immunosorbent assays. Functionality of antibodies against Bordetella pertussis was measured using Bordetella pertussis growth inhibition assay. Results. After maternal Tdap vaccination, 158 infants vaccinated with aP-containing vaccines possessed higher antibody levels (P < .001) against all tested B. pertussis antigens postpriming compared to 157 infants receiving wP-containing vaccines. At 1 month postbooster, only anti-FHA and anti-PRN antibodies were still significantly higher (P < .001) in the aP group. Significantly higher anti-PT and anti-FHA (P < .001), but not anti-PRN immunoglobulin G, were observed among 69 wP-vaccinated infants born to control mothers compared with wP-vaccinated infants of Tdap-vaccinated mothers after primary and booster vaccination. The antibody functionality was higher in all wP-vaccinated infants at all times. Conclusions. Maternal Tdap vaccination inhibited more pertussis-specific responses in wP-vaccinated infants compared to aP-vaccinated infants, and the control group of unvaccinated women had highest PT-specific responses, persisting until after the booster dose. Antibody functionality was better in the wP groups.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 50 条
  • [1] COMPARISON OF ACELLULAR AND WHOLE-CELL PERTUSSIS-COMPONENT DIPHTHERIA-TETANUS-PERTUSSIS VACCINES IN INFANTS
    BLUMBERG, DA
    MINK, CM
    CHERRY, JD
    JOHNSON, C
    GARBER, R
    PLOTKIN, SA
    WATSON, B
    BALLANCO, GA
    DAUM, RS
    SULLIVAN, B
    TOWNSEND, TR
    BRAYTON, J
    GOOCH, WM
    NELSON, DB
    CONGENI, BL
    PROBER, CG
    HACKELL, JG
    DEKKER, CL
    CHRISTENSON, PD
    JOURNAL OF PEDIATRICS, 1991, 119 (02): : 194 - 204
  • [2] Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus- diphtheria vaccines in infancy
    Korkmaz, Huseyin Anil
    Aydin, Adem
    Unal, Belgin
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2014, 34 (03) : 198 - 202
  • [3] Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in senegalese infants
    Simondon, F
    Yam, A
    Gagnepain, JY
    Wassilak, S
    Danve, B
    Cadoz, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (12) : 927 - 932
  • [4] COMPARISON OF A DIPHTHERIA AND TETANUS TOXOIDS AND BICOMPONENT ACELLULAR PERTUSSIS-VACCINE WITH DIPHTHERIA AND TETANUS TOXOIDS AND WHOLE-CELL PERTUSSIS-VACCINE IN INFANTS
    PICHICHERO, ME
    FRANCIS, AB
    MARSOCCI, SM
    GREEN, JL
    DISNEY, FA
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (03): : 295 - 299
  • [5] Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997
    Ekwueme, DU
    Strebel, PM
    Hadler, SC
    Meltzer, MI
    Allen, JW
    Livengood, JR
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (08): : 797 - 803
  • [6] Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants
    Tapiainen, T
    Cherry, JD
    Heininger, U
    VACCINE, 2005, 23 (43) : 5106 - 5112
  • [7] Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy
    Maertens, Kirsten
    Burbidge, Polly
    Van Damme, Pierre
    Goldblatt, David
    Leuridan, Elke
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (12) : 1186 - 1192
  • [8] Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy
    Healy, C. Mary
    Rench, Marcia A.
    Swaim, Laurie S.
    Timmins, Audra
    Vyas, Anuja
    Sangi-Haghpeykar, Haleh
    Ng, Nancy
    Rajam, Gowrisankar
    Havers, Fiona
    Schiffer, Jarad
    Baker, Carol J.
    Kim, Ellie
    Paulos, Simon
    Park, So Hee
    Jeyachandran, Amilia
    Patel, Divya
    VACCINE, 2020, 38 (37) : 5955 - 5961
  • [9] Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines
    Tozzi, AE
    degli Atti, MLC
    Wassilak, SGF
    Salmaso, S
    Panei, P
    Anemona, A
    Luzi, S
    Greco, D
    VACCINE, 1998, 16 (2-3) : 320 - 322
  • [10] Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants A Randomized Clinical Trial
    Munoz, Flor M.
    Bond, Nanette H.
    Maccato, Maurizio
    Pinell, Phillip
    Hammill, Hunter A.
    Swamy, Geeta K.
    Walter, Emmanuel B.
    Jackson, Lisa A.
    Englund, Janet A.
    Edwards, Morven S.
    Healy, C. Mary
    Petrie, Carey R.
    Ferreira, Jennifer
    Goll, Johannes B.
    Baker, Carol J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (17): : 1760 - 1769